ISOLATION AND CHARACTERIZATION OF GENES CODING FOR CARCINOMA-ASSOCIATED ANTIGENS
ISOLATION AND CHARACTERIZATION OF GENES CODING FOR CARCINOMA-ASSOCIATED ANTIGENS
批准号:
3813405
负责人:
J KANTOR
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
DNA DNA methylation antitumor antibody breast neoplasms carcinoembryonal antigen carcinoma colon neoplasms complementary DNA electrophoresis gene expression genetic library genetic transcription glycoproteins immunoglobulin genes interferons molecular cloning monoclonal antibody mucins neoplasm /cancer immunodiagnosis neoplasm /cancer immunology neoplastic transformation nucleic acid hybridization nucleic acid probes proline serine threonine tissue /cell culture transfection tumor antigens
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Monoclonal antibodies (MAbs) have defined several antigens associated with
human carcinomas. Two of the most widely studied antigens are
carcinoembryonic antigen (CEA) and TAG-72. CEA is a 180,000-kd glycoprotein
and TAG-72 is a high- molecular-weight mucin. Recent studies have
demonstrated that CEA belongs to a multigene family related to the
immunoglobulin supergene family. These include CEA, normal cross-reacting
antigen (NCA), biliary glycoprotein (BGP), and human pregnancy-specific
beta 1-glycoprotein (SP1). A 550-base pair CEA probe derived from cloned
complementary DNA was used to carry out Southern analysis of the DNA
isolated from normal and colon tumor cell lines. At high stringency, the
CEA probe detected seven BamHI fragments in all DNAs analyzed. Results of
the Southern analysis demonstrate no amplification or rearrangement of the
CEA genes in tumor cells. Methylation-sensitive restriction endonucleases,
Hpa(II) and Hha(I), were used to compare the degrees of methylation of the
CEA family of genes in normal and colon tumor cell lines. The results
demonstrate that the CEA family of genes exists in a state of
hypermethylation in normal cells. In contrast, the CEA gene(s) are
relatively hypomethylated in the tumor cell lines, suggesting a correlation
between the state of methylation and degree of expression of the CEA
gene(s). Using a CEA cDNA probe, we have investigated the phenomenon of
up-regulation of CEA expression in human tumor cell lines by recombinant
human gamma-interferon (Hu-IFN-gamma). An increase in MAb binding was shown
to be accompanied by a 6- to 11-fold increase in the steady-state levels of
three CEA transcripts with sizes of 4.2, 3.5, and 2.8 kb. Studies are also
in progress to identify and characterize the gene(s) encoding the TAG-72
mucin antigen. A number of mucin genes representing several tissue types
have been cloned. These include the genes encoding the epitopes for breast
cancer, HMFG2, DF3 and H23 and the pancreatic antigen DuPAN-2. Nucleic acid
sequence analysis of these isolated genes has shown them to be identical
and that the difference resides in the sugar epitopes detected by the MAb.
The dominant feature of the breast and pancreatic mucin clones was an
extremely GC-rich, 60-bp tandem repeat sequence that encoded a repeating
peptide unit rich in serine, threonine, and proline.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DESIGN OF LIVE RECOMBINANT VACCINES FOR ACTIVE SPECIFIC IMMUNOTHERAPY
-
批准号:2468459
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
ACTIVE IMMUNOTHERAPY TO HUMAN CARCINOMA ASSOCIATED ANTIGENS
-
批准号:3808563
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
ACTIVE IMMUNOTHERAPY TO HUMAN CARCINOMA ASSOCIATED ANTIGENS
-
批准号:3796509
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
DESIGN OF LIVE RECOMBINANT VACCINES FOR ACTIVE SPECIFIC IMMUNOTHERAPY
-
批准号:6100941
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
RECOMBINANT VACCINES FOR ACTIVE SPECIFIC IMMUNOTHERAPY OF HUMAN CARCINOMA
-
批准号:3752070
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
DESIGN OF LIVE RECOMBINANT VACCINES FOR ACTIVE SPECIFIC IMMUNOTHERAPY
-
批准号:6161041
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
RECOMBINANT VACCINES FOR ACTIVE SPECIFIC IMMUNOTHERAPY OF HUMAN CARCINOMA
-
批准号:5200983
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
MOLECULAR CLONING OF TUMOR ASSOCIATED ANTIGENS
-
批准号:3939340
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
RECOMBINANT VACCINES FOR ACTIVE SPECIFIC IMMUNOTHERAPY OF HUMAN CARCINOMA
-
批准号:3774358
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
MOLECULAR CLONING AND ANALYSIS OF TUMOR-ASSOCIATED ANTIGENS
-
批准号:3916369
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J KANTOR
-
依托单位:
海外基金